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Abstract
Production and release of heat-labile toxin (LT) by wild-type enterotoxigenic
Escherichia coli (ETEC) strains, isolated from diarrheic and asymptomatic Brazi-
lian children, was studied under in vitro and in vivo conditions. Based on a set of 26
genetically diverse LT1 enterotoxigenic E. coli strains, cell-bound LT concentra-
tions varied from 49.8 to 2415 ngmL1. The amounts of toxin released in culture
supernatants ranged from 0% to 50% of the total synthesized toxin. The amount of
LTassociated with secreted membrane vesicles represented o 5% of the total toxin
detected in culture supernatants. ETEC strains secreting higher amounts of LT, but
not those producing high intracellular levels of cell-bound toxin, elicited enhanced
fluid accumulation in tied rabbit ileal loops, suggesting that the strain-specific
differences in production and secretion of LT correlates with symptoms induced in
vivo. However, no clear correlation was established between the ability to produce
and secrete LT and the clinical symptoms of the infected individuals. The present
results indicate that production and release of LT by wild-type human-derived
ETEC strains are heterogeneous traits under both in vitro and in vivo growth
conditions and may impact the clinical outcomes of infected individuals.
Introduction
Enterotoxigenic Escherichia coli (ETEC) strains are food-
borne pathogens that cause diarrhea among travelers and
military personnel visiting or living in endemic regions
(WHO, 1998). Global estimations indicate that ETEC
strains cause 380 000 deaths annually, primarily among
children below 5 years of age, in places where safe food and
water sources are in short supply and deficient sanitation
conditions prevail (WHO, 1998; Black et al., 2003). To cause
disease, ETEC strains must express two sets of virulence-
associated factors: colonization factors (CF or CFA), repre-
sented by a diverse group of fimbrial or afimbrial adhesins
conferring host and tissue specificities, and at least one
enterotoxin type, including the heat-stable toxins (ST) and
the heat-labile toxins (LT) (Nataro & Kaper, 1998). The type
I LTand cholera toxin produced by Vibrio cholerae belong to
a family of structurally, immunologically and phylogeneti-
cally related multimeric AB toxins, which bind to the
respective glycosidic receptors via the pentameric B subunits
(Merrit et al., 1994; Holmes et al., 1995). These toxins are
internalized by epithelial cells and the processed enzymatic
active A1 subunit catalyzes the ADP-ribosylation of the
adenylate cyclase Gsa subunit, resulting in enhanced cAMP
levels and, consequently, altering the ion and water fluxes at
the intestinal lumen, ultimately leading to diarrhea (Hirst
et al., 1984; Spangler, 1992).
An interesting feature of the ETEC infectious process is
the variable symptoms expressed by patients colonized by
different strains. In endemic regions, only a fraction of the
infected individuals display clinical symptoms, ranging
from a mild self-limited diarrhea to a fatal cholera-like
syndrome (Finkelstein et al., 1976; Steinsland et al., 2003).
Indeed, isolation of ETEC strains from asymptomatic
children commonly occurs, particularly for LT1 ETEC
strains (Reis et al., 1982; Viboud et al., 1999; Steinsland
et al., 2003). The variable symptoms expressed by ETEC-
infected patients might reflect acquisition of protective
immunity after repeated exposure to strains displaying
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similar or identical virulence-associated factors (Black
et al., 1981). Nonetheless, the isolation of ETEC strains
from asymptomatic children o 2 years old is intriguing
and quantitative differences in the enterotoxicity of
wild-type ETEC strains may also affect the clinical
symptoms of the infected subjects (Escheverria et al.,
1977).
To bind to the enterocyte receptors and trigger fluid loss,
LT and the closely related cholera toxin must be released
from bacteria into the intestinal lumen. Indeed, the more
severe symptoms of V. cholerae-infected individuals, as
compared to those infected with ETEC strains, have been
attributed to the ability of V. cholerae strains to secrete most
of the synthesized toxin, whereas ETEC strains are believed
to secrete low amounts of LT (Wensink et al., 1978; Gyles,
1992; Wai et al., 1995; Horstman & Kuehn, 2000). More
recent evidence indicated that wild-type ETEC strains can
actively secrete LT into culture supernatants but this
observation is mainly restricted to the H10407 reference
strain and a few other wild-type ETEC strains (Escheverria
et al., 1977; Svennerholm & Holmgren, 1978; Kunkel &
Robertson, 1979; Fleckenstein et al., 2000; Tauschek et al.,
2002). A direct correlation between production and/or
release of LT, as determined under in vitro conditions, and
the symptoms induced by wild-type ETEC strain is still
uncertain.
In this study we determined the amounts of LT pro-
duced and secreted by a set of different LT-producing ETEC
strains isolated from diarrheic and asymptomatic Brazilian
children. The results indicated that the production and
secretion of LT are independently regulated and represent
specific and characteristic traits of wild-type ETEC strains.
Additionally, we observed that the capacity of ETEC strains
to secrete LT, as determined under in vitro conditions,
correlates with fluid accumulation in the rabbit ileal loop
assay.
Materials and methods
Bacterial strains and growth conditions
The 26 LT1 ETEC strains included in the present work were
derived from case-control studies of acute endemic child-
hood diarrhea in Brazil from children under the age of 5
(Gomes et al., 1996; Re´gua-Mangia et al., 2004). Eleven LT1
ETEC strains were isolated from asymptomatic children,
and 15 LT1 strains were recovered from diarrheic children
requiring medical assistance. The reference LT1/ST1 ETEC
H10407 strain was isolated from a patient with severe
cholera-like disease in Bangladesh (Evans et al., 1975). Table
1 lists all tested ETEC strains and respective serotypes,
colonization factors, geographic origin, toxigenic profiles,
and clinical features. One plasmid-cured nontoxinogenic
derivative of the ETEC 4611-4 (O159:H21) strain originally
isolated from a diarrheic subject was used as a negative
control for LT production. Cultures were routinely prepared
in CAYE medium (2% Casamino acids, 0.6% yeast extract,
43mM NaCl, 38mM K2HPO4, 0.1% trace salt solution
consisting of 203mMMgSO4, 25mMMnCl2, 18mM FeCl3)
(Mundell et al., 1976) and incubated 18 h at 37 1C with
vigorous agitation (200 r.p.m. in a rotary shaker).
LT production and secretion assays
LT production was determined with cultures prepared in
CAYE broth after overnight incubation at 37 1C with aera-
tion. After incubation, the same amount of bacterial cells
(corresponding to 13–14 OD600 nm) of each sample was
centrifuged at 3000 g for 15min and the culture super-
natants saved for determination of secreted LT. Cell-bound
toxin was determined in whole cell extracts prepared after
suspension of bacteria in 3mL of phosphate-buffered saline
(PBS) buffer (100mM phosphate, 150mM NaCl, pH 7.2)
followed by sonic disruption with a Branson sonifier 450D.
Cell debris was removed by centrifugation at 5000 g for
15min at 4 1C and supernatants, corresponding to cell-
associated LT, assayed immediately or stored at  20 1C for
up to 7 days. Determination of LT concentrations in culture
supernatants and whole cell extracts was based on at least
three independent determinations for each tested ETEC
strain.
Determination of LT associated with membrane
vesicles
The amount of secreted LT associated with membrane
vesicle was determined as previously described by Horstman
& Kuehn (2000). After cultivation in CAYE broth, bacterial
cells were centrifuged (10 000 g, 10min) and culture super-
natants filtered through a disposable 0.22-mm nitrocellulose
filter. Half of the filtrate sample was incubated with 100mM
EDTA at 37 1C for 120min. Both samples were submitted to
GM1-ELISA for determination of the total amount of
soluble LT. Differences in the amount of LT determined in
EDTA-treated and nontreated samples were attributed to
the encapsulation of LT into membrane vesicles.
Capture ELISA (cELISA) and GM1-ELISA
Determination of LT concentrations in culture supernatants
or whole cell extracts was carried out with the capture ELISA
method (Drevet & Guinet, 1991). Briefly, microtiter plates
(Nunc Maxisorp, Nalge Nunc, Roskilde, Denmark) were
coated with 100 mLwell1 of rabbit anticholera toxin serum
(titer of 3.3 105) diluted in PBS (1 : 1000) followed by
overnight incubation at 4 1C. Plates were washed twice with
PBS containing 0.05% Tween-20 (PBS-T) and blocked by
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incubation with 5% skim milk in PBS-T for 1 h at 37 1C.
After additional washings, 100 mL of crude and serially
twofold diluted samples were added to the wells and
incubated for 2 h at room temperature. After washings,
mouse anti-LT serum (titer of 105) diluted in PBS-T
(1 : 5000) was added to the wells and incubated for 90min.
Detection of bound antibodies was carried out with 100 mL
of PBS-T diluted (1 : 3000) horseradish peroxidase-conju-
gated antimouse-IgG (Sigma-Aldrich, Poole, UK) incubated
for 90min at room temperature. After a final washing step,
color reactions were developed with o-phenylenediamine
and H2O2. After 20min at room temperature, the reactions
were interrupted by the addition of 2M H2SO4
(50mLwell1) and the OD492 nm measured in a microplate
reader (Multiskan EX, ThermoLabsystems). The final reac-
tion values were obtained after deduction of background
absorbance measured in control wells filled with cell extracts
of the LT derivative of the 4611-4 strain. The GM1-ELISA
was carried out as previously described (Ristaino et al.,
1983). Briefly, wells of polystyrene 96-well microtiter plate
(Nalge Nunc) were coated with PBS-diluted GM1 ganglio-
side (2mgmL1) (Sigma-Aldrich) and incubated overnight
at room temperature. In the following day, plates were
washed and then blocked with 0.1% bovine serum albumin
(BSA) in PBS for 30min at 37 1C. After washing with PBS-T,
undiluted bacterial extracts were dispensed in duplicate
wells and then twofold serially diluted. All subsequent steps
were identical to cELISA. LT concentrations in tested
samples were determined using purified LT isolated from
the H10407 strain. Regression analysis (R24 0.98) was used
to generate a standard curve used for determination of LT
concentrations in the tested samples.
Purification of LT
A recombinant E. coli DH5a strain harboring the
pBSPKS() vector (Schweizer, 2001) carrying the complete
elt operon of the H10407 strain under the control of the
Table 1. Production and release of LT by wild-type ETEC strains isolated from diarrheic and asymptomatic children in Brazil
Strain Serotype Other traits Source
LT (ng mL1)
Total LT production
(ng mL1)w
LT secretion
(%)zCells Supernatants
1372-1 O23:H28 CS AC 746.7 28.1 3 0.6 749.7 0.4
4092-7 ND:H21 CS AC 1206.5 264.1 182.6 42.7 1389.1 13.1
4692-5 ND:H CS AC 478.2 57.0 55.1 12.4 533.3 10.3
4702-1 O167:H5 CS AC 76.0 12.5 71.3 21.9 147.3 48.4
4652-2 O159:H34 CS AC 49.8 0.95 o 2 o 51.8 o 0.04
63V O159:H17 – AC 696.1 81.1 122.4 45.5 818.5 14.9
121I O48:H21 – AC 63.1 11.9 4.6 3.1 67.7 6.8
PE0215 O7:H18 ND AC 277.1 42.8 52.2 9.1 329.3 15.9
PE0534 O106:H40 ND AC 182.9 58.7 78.0 6.2 260.9 29.9
PE0690 ONT:H8 ND AC 258.1 40.1 127.1 14.6 385.2 32.9
PE0415 O152:H2 ND AC 264.9 26.9 32.8 8.9 297.7 11.0
4811-1 O9:H21 CS DC 53.8 6.6 52.7 9.4 106.5 49.5
4101-1 O114:H CS DC 1463.6 327.3 93.6 13.0 1557.2 6.0
4321-1 ND:H CS DC 78.7 17.3 7.2 3.2 85.9 8.4
214III ONT:HNT – DC 54.1 12.7 20.8 3.1 74.9 27.8
225IV O148:H28 CS6 DC 55.4 19.4 13.3 6.4 68.7 19.4
PE0615 ONT:H19 ND DC 82.5 15.2 49.4 2.3 131.9 37.5
2811-1 O88:H25 CS DC 2415.3 706.9 109.8 5.9 2525.1 4.4
136I O88:H25 – DC 446.0 22.6 64.7 8.2 510.7 12.7
136II O88:H25 ND DC 897.4 74.4 54.4 11.4 951.8 5.7
136III O88:H25 ND DC 541.1 36.7 90.3 57.3 631.4 14.3
36III O159:H21 – DC 602.4 89.8 166.2 6.6 768.6 21.6
36IV O159:H21 – DC 623.4 27.9 161.7 8.1 785.1 20.6
187V O159:H21 – DC 337.0 53.7 139.3 18.1 476.3 29.2
PE0260 O8:H9 ND DC 504.8 54.8 103.0 13.3 607.8 16.9
PE0262 O8:H9 ND DC 105.9 16.1 102.8 7.1 208.7 49.3
H10407 O78:H11 ST1 CFA/I DC 526.2 57.0 248.2 65.6 774.4 32.0
LT values determined with cELISA using whole cell extracts (cells) or culture supernatants of the different ETEC strains cultivated overnight (18 h) in
CAYE at 37 1C under aeration. Values expressed by means SD of at least three independent experiments.
wValues expressed as means of LT measured in bacterial cells plus LT detected in culture supernatants.
zLT secretion expressed as the ratio of LT detected in culture supernatant/total LT produced by the strain  100.
ND, not determined; NT, nontypeable; AC, isolated from an asymptomatic child; DC, isolated from a diarrheic child.
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native promoter was used for the expression of LT. The toxin
was purified by affinity chromatography on immobilized D-
galactose columns (Pierce, Rockford, IL), according to a
previously described method (Uesaka et al., 1994). The
purified toxin was monitored in SDS-containing 15% poly-
acrylamide gels (Laemmli, 1970), and the protein concen-
tration determined with the Bradford assay (Bio-Rad
Laboratories, Hercules, CA) and BSA (Sigma-Aldrich) as
standard.
Production of anticholera toxin and anti-LT
antibodies
Cholera toxin-specific serum was obtained after subcuta-
neous immunization of an adult New Zealand rabbit with
four doses of 15 mg of purified cholera toxin (Sigma-
Aldrich) in Freund incomplete adjuvant at 2-week intervals.
Blood samples were harvested by cardiac puncture of the
animal 1 week after the last dose. Sera were separated from
cells, pooled and stored at  20 1C. The anti-LT serum was
prepared with female C57Bl/6 (6–8-week-old) mice immu-
nized subcutaneously with purified LT (10mg). The immu-
nization regimen consisted of one dose applied in complete
Freund adjuvant followed by two additional doses in in-
complete Freund adjuvant given at weekly intervals. One
week after the last dose, the blood was harvested, sera
collected, pooled, and stored at  20 1C.
Screening for the presence of gsp and leoA
genes
The presence of the gspD and gspK genes, involved in the
type II secretion pathways, in the LT1 ETEC strains was
determined according to the conditions described by
Tauschek et al. (2002). Genomic DNA of the ETEC strains
was prepared by the boiling lysis method and amplifica-
tion reactions were carried out with primers P78
(50-TTCGGAAATCGCCCGCGTGC) and P109 (50-
TCCACCTTCGAGACTTCC), for the gspD gene, and with
primers P5 (50-GCAGCAGGTGACTAACGGC) and P12 (50-
CAGGGCTTAACCACGGGTC) for the gspK gene. The leoA
gene has been reported to be involved in a specific LT
secretion pathway (Fleckenstein et al., 2000). Attempts to
detect the leoA gene were based on primers 102.wr001
(50-TCAGCCGCTCATCGTCCATCA) and 102.wr008 (50-
GTAAAACCGCACTGGACT). Amplifications were per-
formed with High Fidelity DNA polymerase (Fermentas, St
Leon-Rot, Germany) in a reaction volume of 25 mL in a
Mastercycler Gradient thermal cycler (Eppendorf) with an
initial denaturation step of 5min at 94 1C, followed by 35
cycles of 30 s at 94 1C, 30 s at 55 1C, and 1min at 72 1C, with
a final extension for 5min at 72 1C.
Rabbit ileal loop assay
Rabbit ileal loop studies were performed as previously
described (De & Chatterje, 1953; Nishibuchi et al., 1992)
with 1.5-kg male New Zealand white rabbits. Rabbits were
fasted for 48 h prior to surgery, except for ingestion of water
with glucose. Laparotomy was carried out aseptically to
externalize the intestine of the animals, which were kept
under anesthesia by intramuscular administration of telazol
(200 mL kg1) and nilperidol (300mL kg1). Isolated 50-cm
duodenum loops were spaced by 2-cm interposing loops
with ligatures. Strains with different levels of the LT produc-
tion and secretion (1372-1, 4652-2, 2811-1, 36III), as well as
both negative and positive controls (4611-4 and H10407,
respectively), were cultivated from single colonies in 30mL
of CAYE broth overnight. Aliquots (500mL) containing
107 CFUmL1 were injected into each loop followed by
intestine internalization and incision closure. The volumes
of accumulated fluids in each loop were measured c. 18 h
after the inoculation of the bacterial strains.
Statistical evaluations
Statistical analyses were carried out with the Student’s t-test
and ANOVA for repeated measurements. P values o 0.05 were
taken as indicative of statistical significance.
Results
Quantification of LT produced and released by
wild-type ETEC strains
Twenty-six LT-producing wild-type ETEC strains isolated
from asymptomatic (11 strains) or diarrheic children (15
strains) living in Brazil were analyzed for the ability to
produce and release LT after growth at 37 1C for 18 h in
CAYE medium. Determination of the LT content in whole
cell extracts and culture supernatants indicated that these
strains were remarkably variable with regard to LT produc-
tion and secretion (Table 1). Cell-bound LTwas produced at
concentrations ranging from 50 to 1389 ngmL1 among
ETEC strains isolated from asymptomatic patients. The
concentration of LT in whole cell extracts of ETEC strains
recovered from diarrheic patients varied from 53.8 to
2415 ngmL1. For comparison, the amount of cell-bound
LT produced by the reference H10407 strain cultivated
under the same conditions was 526.2 ngmL1. Eight of 11
(72%) ETEC strains isolated from asymptomatic children
and 10 of 15 (71.5%) strains isolated from diarrheic patients
produced LT levels above 100 ngmL1 (Table 1). Accord-
ingly, no statistically significant differences (P= 0.63781)
could be detected after comparing the values of cell-bound
LT produced by ETEC strains isolated from symptomatic or
asymptomatic subjects (Fig. 1). The same result was
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obtained with LT secreted in culture supernatants. The
amounts of LT detected in culture supernatants of ETEC
strains isolated from asymptomatic subjects varied from
nondetectable levels to 182.6 ngmL1, and the secreted LT
values for strains derived from diarrheic children ranged
from 7.2 to 166 ngmL1 (Table 1). In comparison, the
amount of LTsecreted by the H10407 strain cultivated under
the same culture conditions was 248.2 ngmL1, representing
32% of the total synthesized toxin. Secretion of LT among
the tested ETEC strains ranged from 0% to 49% of the
produced toxin, indicating that LT secretion is regulated
independently of toxin expression. Once again, no statisti-
cally significant differences could be demonstrated between
the values of secreted LT by wild-type ETEC strains and the
clinical symptoms of the infected individuals (Fig. 1).
Considering the total amounts of LT (secreted plus cell-
bound toxin), wild-type ETEC strains were capable of
producing LT at concentrations ranging from c. 50 to
2525 ngmL1. These results clearly demonstrate that
both production and secretion of LT by wild-type ETEC
strains isolated from human beings are remarkably
variable traits, at least as evaluated under laboratory condi-
tions.
LT secretion pathways in wild-type ETEC strains
In contrast to V. cholerae, ETEC strains were initially
reported to be defective in LT secretion (Kunkel & Robert-
son, 1979; Hirst et al., 1984). However, further reports
indicated that some ETEC strains are proficient in the
secretion of LT by at least three different mechanisms
(Fleckenstein et al., 2000; Horstman & Kuehn, 2002;
Tauschek et al., 2002). As an initial step toward the analysis
of the molecular mechanisms controlling the variable LT
secretion expressed by wild-type ETEC strains, we detected
the presence of two genes, gspD and gspK, that played
essential roles on the extracellular secretion (EPS) pathway
required for LT secretion in the H10407 strain (Tauschek
et al., 2002). All 26 LT1 ETEC strains studied, as well as the
reference H10407 strain, were positive for the presence of
the gspD and gspK genes, whereas no productive amplifica-
tion was achieved with E. coli K12 strains (data not shown).
On the other hand, attempts to amplify the leo gene, another
gene encoding a putative LT-secretion pathway (Flecken-
stein et al., 2000), were unsuccessful in all tested ETEC
strains.
In addition to the EPS pathway, ETEC strains have
been reported to promote LT secretion by means of mem-
brane vesicles shed during active growth (Horstman &
Kuehn, 2000, 2002). One possible explanation for the
variable secreted LT levels by wild-type ETEC strains
might involve the differential shedding of membrane
vesicles. As shown in Fig. 2, the amount LT associated with
membrane vesicles represented o 5% of the total toxin
detected in culture supernatants of different ETEC strains.
Additionally, no significant differences between the relative
amounts of LT associated with membrane vesicles gene-
rated by ETEC strains releasing high (4092-7, 36III, and
2811-1 strains) or low LT values (4652-2 and 1372-1 ETEC
strains) could be detected. These data suggest that the
variable amount of LT secreted cannot be ascribed to the
differential shedding of membrane vesicles by wild-type
ETEC strains.
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Fig. 2. Association of LT to membrane vesicles secreted by wild-type
ETEC strains. Culture supernatants harvested from ETEC cultures kept at
37 1C for 18 h were incubated with 100 mM EDTA for 120 min before
measurement of the LTcontents by GM1-ELISA. ETEC H10407 and E. coli
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Secretion of LT correlates with fluid
accumulation in rabbit ileal loops
Production and release of LT in the intestinal lumen of
mammals may differ from values determined with ETEC
strains cultivated under ordinary laboratory conditions
(Hunt & Hardy, 1991). To determine whether the in vitro
determined LT values correlate with the in vivo behavior of
ETEC strains, we tested four wild-type strains (1372-1,
4652-2, 2811-1, 36III) and two reference strains (H10407
and 4611-4) in ligated rabbit ileal loops. Under in vitro
conditions, 1372-1 and 4652-2 strains secreted low LT levels
(3 ngmL1 or non detectable, respectively), and 2811-1,
36III and H10407 strains secreted much higher LT levels
(109.8, 166.2 and 248.2 ngmL1, respectively) (Table 1). On
the other hand, the amounts of cell-bound LT produced by
1372-1, 36III and H10407 strains were similar (c.
630 ngmL1), whereas 4652-2 and 2811-1 strains produced
the lowest (49.8 ngmL1) and the highest (2415 ngmL1) LT
values among the tested ETEC strains, respectively. Using
the ligated rabbit ileal loop model we observed that ETEC
strains secreting low LT levels (1372-1 and 4652-2) caused
little or no fluid accumulation even when the amount of
cell-bound LTwas high, as in the case of strain 1372-1 (Fig.
3). On the other hand, ETEC strains secreting larger
amounts of LT, as determined under in vitro conditions,
caused proportionally more intestinal fluid accumulation,
as shown with the 2811-1, 36III and H10407 strains. Inter-
estingly, the 2811-1 strain, although producing approxi-
mately three times more toxin than the H10407 strain,
induced significantly less fluid accumulation than the
H10407 strain, which secretes roughly twice as much LT.
These results clearly indicate that the amount of secreted LT
is the most relevant determinant of fluid accumulation in
the rabbit ileal loop model. Moreover, these results strongly
suggest that the values of LT produced and secreted by ETEC
strains under in vitro conditions correlate with the amounts
of toxin produced during in vivo growth.
Discussion
Since the discovery and characterization of LT, the capacity
of production and release of the toxin expressed by ETEC
strain has been considered one of the most relevant viru-
lence-associated factors of wild-type strains isolated from
human and nonhuman hosts. Moreover, the variable degree
of enterotoxigenicity expressed by wild-type ETEC strains
has been suggested to contribute to the severity of the
disease symptoms of infected patients (Escheverria et al.,
1977). In the present report, we carried out a systematic
quantitative analysis of LT produced and released by a set of
26 wild LT1 ETEC strains isolated from either diarrheic or
asymptomatic children living in Brazil. Our data showed
that production and release of LT represent variable but
reproducible traits expressed by wild-type ETEC strains
cultivated under laboratory conditions. Although no clear
correlation could be drawn between the clinical symptoms
of infected subjects and the enterotoxigenicity of the tested
strains, our evidence indicated that fluid accumulation in
rabbit ileal loops is proportional to the amount of secreted
LT, thus suggesting that in vitro determined LT levels
correlate with the in vivo effects inflicted by LT1 ETEC
strains.
The variable expression of LT by wild-type ETEC strains
indicates that regulation of elt operon is complex and
subject to strain-specific regulation. Regulation of LT pro-
duction involves the interplay of the histone-like nucleoid
structuring (H-NS) repressor protein as the main modula-
tor of gene expression. Available evidence indicates that the
plasmidial eltAB operon is silenced by the H-NS protein,
which binds to a downstream regulatory element (DRE)
blocking the extension of the mRNA for RNA polymerase
under lower temperature or osmolarity (Trachman & Maas,
1998; Trachman & Yasmin, 2004). LT expression by wild-
type ETEC strains may vary from 50 to values above
2400 ngmL1 under the same culture conditions, which
suggests that additional factors, such as promoter strength,
plasmid copy number or alternative gene regulation me-
chanisms, contribute to the activity of the elt operon.
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wild-type ETEC strains. Exponentially growing ETEC cells harvested from
cultures prepared in CAYE broth at 37 1C were adjusted to a cell
concentration of 107 CFU mL1 and 500-mL aliquots inoculated into ileal
loops. After 18 h the animals were sacrificed and the volume of liquid in
each ileal loop measured. Results were based on experiments carried out
with four rabbits and include the H10407 and 4611-4 strains as positive
and negative controls, respectively. Error bars indicate standard devia-
tions. Cell-bound and -secreted LT produced by each tested ETEC strain
are expressed in ng mL1 and were determined in vitro using cELISA.
Statistically different values (Po 0.01) as compared to the negative
control (4611-4 strain).
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Indeed, differences in promoter strength and the presence of
trans-acting gene regulation mechanisms have already been
demonstrated in E. coli K12 strains transformed with LT-
encoding plasmids isolated from wild-type ETEC strains
(Neill et al., 1983).
Initial reports have indicated that, in contrast to V.
cholerae, ETEC strains were not proficient at secreting LT
into the extracellular medium (Hirst et al., 1984; Clements
et al., 1985). Later, additional evidence demonstrated that
ETEC strains are in fact capable of promoting the active
secretion of LT by at least three different mechanisms,
including the general secretory pathway encoded by gsp
genes (Tauschek et al., 2002), an ETEC-specific secretion
pathway encoded by the leo gene (Fleckenstein et al., 2000),
and the shedding of LT-containing membrane vesicles
(Horstman & Kuehn, 2002). The present data demonstrated
that the amount of LT released in the culture supernatants
ranged from undetectable levels up to 250 ngmL1, 0–50%
of the toxin produced by the tested strain. All tested ETEC
strains harbored the gspD and gspK genes involved in the
extracellular protein secretion machinery but we failed to
demonstrate the presence of the leo gene. The amounts of LT
associated with membrane vesicles represented only a small
fraction of the total released toxin and, thus, could not
explain the quantitative differences in the observed secreted
LT values. This indicates that the strain-specific differences
in LT secretion cannot be explained solely on the basis of the
secretion mechanisms so far described and suggests that the
additional pathways affecting LT release exist in wild-type
ETEC strains. The recent description of a plasmid-encoded
two-partner secretion pathway found in the H10407 strains
illustrates the complexity and diversity of the protein
secretory mechanisms expressed by ETEC strains (Flecken-
stein et al., 2006).
The in vivo action of LT implies that the toxin is released
into the intestinal lumen and binds to receptor molecules on
the surface of enterocytes, leading to internalization of the
toxin and subsequent activation of adenylate cyclase. The
mammalian small intestine environment is clearly distinct
from those encountered under ordinary laboratory condi-
tions, differing in pH, oxygen tension, osmolarity and the
presence of bile salts (Kunkel & Robertson, 1979; Hunt &
Hardy, 1991). In this work we compared the in vivo
production of LT by wild-type ETEC strains producing
different amounts of secreted or cell-bound LT using the
tied rabbit ileal loop model. With this in vivo model, ETEC
strains secreting larger amounts of toxin, but not those
producing higher cell-bound toxin, accumulated more
liquid in rabbit intestinal loops. These results indicate that
amounts of LT produced and secreted in vitro by ETEC
strains correlate with the in vivo expression of the toxin and
suggest that host-associated factors, such as the presence of
bile salts, did not change the behavior of wild-type strains
with regard to LT secretion. The recent finding that LT1
producing strains more efficiently colonize both gnotobiotic
piglets and mice in a newly developed colonization model
presents another aspect of the role LT plays in the virulence
of ETEC strains (Berberov et al., 2004; Allen et al., 2006).
This evidence further supports the notion that the hetero-
geneous LT production detected among wild-type strains
may affect the symptoms of ETEC-infected individuals.
Individuals infected with ETEC strains may develop
symptoms ranging from a mild illness to a severe cholera-
like diarrhea (Finkelstein et al., 1976). Such differences are
not easily accounted for by our present understanding of
ETEC pathogenesis. However, the variable enterotoxicity
concerning production and release of LT may, at least in
part, affect the clinical symptoms of an infected subject,
particularly among young children and travellers without
previous contact with the pathogen. Nevertheless, no clear
correlation could be established between the LT levels
produced or secreted by LT1 ETEC strains and the sympto-
matic or asymptomatic state of the infected children. As
previously shown by other groups, children living in en-
demic regions are prone to develop LT-specific immunity
that confers protection against subsequent infections with
LT1-producing strains (Steinsland et al., 2003). Unfortu-
nately, serum and fecal samples of children infected with the
ETEC strains included in the present study were not avail-
able and, thus, the presence of LT-specific antibody re-
sponses could not be determined. Nonetheless, due to the
frequent infections with different ETEC strains, correlation
between LT1 production/secretion and severity of clinical
symptoms is unlikely to be demonstrated among children
living in endemic regions and would more properly tested in
subjects not previously exposed to ETEC.
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